Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT05633485 Completed - COVID-19 Pandemic Clinical Trials

Animation Supported COVID-19 Education

COVID-19
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

Introduction: The COVID-19 epidemic and related mutations, which affect the whole world, continue to increase globally. In particular, this crisis adversely affects school-age children's quality of life. Method: The study was carried out between February and April 2022 following the experimental research criteria with the pretest-posttest-retest control group. The research population consists of 4th-grade primary school students studying in schools affiliated with the Siirt Directorate of National Education. The sample consists of 148 students studying in the 4th grade at two schools deemed suitable for the conduct of the study. Data were collected using data collection materials, the Descriptive Questionnaire, and the General Child Quality of Life Scale. Results: The mean age of all students participating in the study was 10.53±2.60, 53% of the students were girls, and 47% were boys. It has been determined that 36.0% of the Students have not received any training on COVID-19 before, 32.4% of them did not take precautions to defend themselves from COVID-19 disease, and it is not possible to protect 48.4% of them from COVID-19 disease even if adequate precautions are taken. It was found that the difference between the pretest, posttest, and retest mean scores of the Students in the experimental group on the quality of life scale was statistically significant (p < 0.05). It was determined that the mean of life quality increased immediately after the training but decreased in the measurements one month later. Conclusion: Education to be given to school-age children should be developed with animation-supported programs.

NCT ID: NCT05633472 Recruiting - Clinical trials for Post-acute COVID-19 Syndromes

The Roles of Vitamin D and Microbiome in Children With Post-acute COVID-19 Syndromes (PACS) and Long COVID

Start date: October 18, 2022
Phase: N/A
Study type: Interventional

A double-blind study to evaluate the role of human microbiome and vitamin D in the development of long COVID and PACS in children.

NCT ID: NCT05633446 Not yet recruiting - COVID-19 Clinical Trials

Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

Start date: May 23, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The study aims to investigate the safety and immunogenicity of one dose vs two doses of a T-cell priming next-generation vaccine against Coronavirus disease.

NCT ID: NCT05633433 Recruiting - Clinical trials for SARS-CoV-2 Infection

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

Start date: December 29, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected with SARS-CoV-2

NCT ID: NCT05633420 Completed - COVID-19 Clinical Trials

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

Start date: July 24, 2022
Phase: Phase 2
Study type: Interventional

This study is a multi-center, single-arm, open-label, pilot clinical trial to explore efficacy and safety of Pyramax in mild to moderate COVID-19 patients

NCT ID: NCT05633368 Completed - Covid-19 Clinical Trials

Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive Therapy

COVID-M-ECT
Start date: March 31, 2020
Phase:
Study type: Observational

Electroconvulsive therapy is a safe and effective therapeutic strategy in patients with treatment resistant depression. As relapse after successful ECT is significant even with adequate pharmacological strategies, continuation (up to 6 months after completion of index-ECT) or maintenance ECT (more than 6 months after index-ECT) is often necessary to maintain remission. During the current Covid-19 pandemic hospitals redirected resources and closed or significantly diminished ECT services. In this study we aim to assess the impact of discontinuing maintenance electroconvulsive therapy in patients diagnosed with unipolar depressive disorder.

NCT ID: NCT05631145 Completed - Depression, Anxiety Clinical Trials

MT Combined With XKSA for Depressive Symptoms During COVID-19

Start date: May 3, 2020
Phase: N/A
Study type: Interventional

Social isolation related mental health problems have raised many concerns during the COVID-19 outbreaks. Mental health care for people in quarantined hotels is in urgent need, but concrete program is rarely reported. Morita therapy and acupressure have been identified as effective treatments for regulating mood and sleep. The study aimed to examine whether Morita therapy (MT) combined with Xingnao Kaiqiao self-administered acupressure (XKSA) could improve depressive, anxiety symptoms and sleep quality in isolated people with depressive symptoms.

NCT ID: NCT05630599 Active, not recruiting - Covid19 Clinical Trials

Remote Assessment of Lung Disease and Impact on Physical and Mental Health

RALPMH
Start date: July 26, 2021
Phase:
Study type: Observational

This cohort study aims to use the open-source RADAR-base mHealth platform to collect and analyze datasets associated with lung disease. This will include continuous data collected from wearable devices (e.g. heart rate, oxygen saturation, respiratory rate), including pulse oximeters, spirometer, mobile phones, digital tests, and smart phone symptom questionnaires.

NCT ID: NCT05630378 Completed - COVID-19 Clinical Trials

Evaluation of an Integrative Medicine Outpatient Clinical Setting for Post-COVID-19 Patients

TaPoCo
Start date: May 11, 2022
Phase: N/A
Study type: Interventional

The study aims to identify whether a multimodal integrative naturopathy outpatient clinical concept can improve the symptoms of patients suffering from post-COVID-Syndrome. Main outcome is fatigue. The outpatient clinical programme consists of 11 weeks wherein patients visit the clinic one day per week. The pillars of classical naturopathy are combined with extended naturopathy and complementary procedures. Previous naturopathical studies on patients with chronic fatigue syndrome could find numerous indications that different types of naturopathy can help patients with fatigue.

NCT ID: NCT05630365 Completed - COVID-19 Clinical Trials

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal Swabs

Start date: December 15, 2022
Phase: N/A
Study type: Interventional

This study is designed as an international, prospective, multicentric, clinical study to investigate the performance of the Panbio™ COVID-19/Flu A&B Rapid Panel for the qualitative detection of COVID-19 antigen, Influenza A antigen, and Influenza B antigen in human mid-turbinate nasal swabs collected by a trained health worker. This study is part of the performance evaluation to support the CE conformity assessment procedures.